HeartBeam to Participate in the H.C. Wainwright Global Investment Conference May 23-26, 2022

Author's Avatar
May 18, 2022

HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, announced today it will participate virtually in the H.C. Wainwright Global Investment Conference being held in-person and virtually May 23 – 26, 2022.